XML 69 R37.htm IDEA: XBRL DOCUMENT v3.19.1

Earnings per Share (Tables)

3 Months Ended

Mar. 31, 2019

Earnings Per Share [Abstract]

Basic and diluted earnings per share

Basic and diluted earnings per share are calculated as follows:

	For the Three Months Ended March 31,
(In millions)	2019				2018
Numerator:
Net income attributable to Biogen Inc.	$	1,408.8			$	1,172.9
Denominator:
Weighted average number of common shares outstanding	196.6				211.4
Effect of dilutive securities:
Stock options and employee stock purchase plan	—				—
Time-vested restricted stock units	0.3				0.2
Market stock units	0.1				0.1
Performance stock units settled in stock	—				—
Dilutive potential common shares	0.4				0.3
Shares used in calculating diluted earnings per share	197.0				211.7

X

- References

No definition available.

+ Details

Name:	us-gaap_EarningsPerShareAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration